MyFinsight
Home
Blog
About
Contact
Download
Download image
Total revenue
$139,071K
Gross profit
$101,159K
Other income, net
$7,328K
Canceled cashflow
$37,912K
Net income
$28,707K
Stock-based compensation
$12,761K
Canceled cashflow
$79,780K
Depreciation and
amortization
$5,430K
Accounts payable
$2,587K
Noncash lease expense
$732K
Loss on disposal of
property, plant and...
-$366K
Cost of
revenue-Testing
$33,306K
Intangible asset
amortization - cost of revenue
$2,707K
Cost of
revenue-Product
$1,891K
Cost of
revenue-Biopharmaceutical And Other
$8K
Allocation of facilities
and it expenses
-$6,027K
Net decrease in
cash, cash...
-$99,433K
Net cash provided by
operating activities
$35,215K
Canceled cashflow
$15,368K
Total selling and
marketing
$27,156K
Total research and
development
$27,098K
Total general and
administrative
$23,680K
Income tax provision
$1,267K
Intangible asset
amortization - operating...
$579K
Canceled cashflow
$6,027K
Laboratory supplies and
reagents expense
$12,314K
Compensation expense
$9,804K
Other cost
$4,937K
Sample collection
expense
$3,288K
Allocation of facilities
and it expenses
$2,963K
Product costs
$1,401K
License fees and
royalties
$313K
Other cost
$174K
Allocation of facilities
and it expenses
$3K
Other cost
$8K
Decrease in cash, cash
equivalents and restricted...
-$99,375K
Effect of foreign
currency on cash, cash...
-$58K
Canceled cashflow
$35,215K
Proceeds from the
exercise of common stock...
$2,735K
Accrued liabilities and
deferred revenue
-$6,120K
Accounts receivable
$5,567K
Prepaid expenses and
other current assets
$1,306K
Supplies
$870K
Amortization of discount on
short-term investments
$614K
Revaluation of
acquisition-related contingent...
-$350K
Operating lease
liabilities
-$319K
Other assets
$132K
Effect of foreign
currency on operations
$80K
Deferred income taxes
-$10K
Compensation expense
$19,972K
Other selling and
marketing expenses
$4,561K
Direct expense
$1,455K
Allocation of facilities
and it expenses
$1,168K
Compensation expense
$15,547K
Other research and
development expenses
$5,460K
Direct expense
$4,198K
Allocation of facilities
and it expenses
$1,893K
Compensation expense
$16,236K
Other general and
administrative expenses
$13,471K
Net cash used in
investing activities
-$127,961K
Net cash used in
financing activities
-$6,629K
Canceled cashflow
$2,735K
Purchase of short-term
investments
$124,999K
Purchases of property,
plant and equipment
$2,962K
Payment of taxes on
vested restricted...
$9,364K
Back
Back
Cash Flow
VERACYTE, INC. (VCYT)
VERACYTE, INC. (VCYT)
source: myfinsight.com